Expanding U.S. market access with an experienced technology investor and AI-driven growth strategistVancouver, British Columbia--(Newsfile Corp. - December 30, 2025) - BioMark Diagnostics Inc. (CSE: ...
TipRanks on MSN
BioMark leverages landmark lung cancer studies and new funding to drive 2026 expansion
BioMark Diagnostics ( ($TSE:BUX) ) has issued an announcement. BioMark Diagnostics reported a transformative 2025 marked by major capacity ...
Company engages Standards Council of Canada; targets ISO 15189 accreditation for early 2026Vancouver, British Columbia--(Newsfile Corp. - December 23, 2025) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: ...
BioMark Diagnostics ( ($TSE:BUX) ) has issued an update. BioMark Diagnostics has appointed technology investor and AI-focused growth strategist ...
BioMark is pioneering liquid biopsy solutions for challenging conditions and championing equity in diagnosis The diagnostic delay for rare diseases varies from months to decades, and some may never ...
Detailed price information for Biomark Diagnostics Inc (BUX-CN) from The Globe and Mail including charting and trades.
Vancouver, British Columbia--(Newsfile Corp. - November 5, 2024) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTCMKTS: BMKDF) ("BioMark"), a leading developer of liquid biopsy tests for early ...
BioMark Diagnostics Inc. Annual stock financials by MarketWatch. View the latest BUX financial statements, income statements and financial ratios.
BioMark Diagnostics Inc. Annual stock financials by MarketWatch. View the latest BMKDF financial statements, income statements and financial ratios.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback